Characterization and subcellular localization of murine and human magnesium-dependent neutral sphingomyelinase
about
Cloning and characterization of the mammalian brain-specific, Mg2+-dependent neutral sphingomyelinaseCeramide-induced apoptosis in renal tubular cells: a role of mitochondria and sphingosine-1-phoshateRoles and regulation of neutral sphingomyelinase-2 in cellular and pathological processesPhosphatidylserine and phosphatidylethanolamine in mammalian cells: two metabolically related aminophospholipidsCoordination between fission yeast glucan formation and growth requires a sphingolipase activityA neutral sphingomyelinase resides in sphingolipid-enriched microdomains and is inhibited by the caveolin-scaffolding domain: potential implications in tumour necrosis factor signallingIdentification and characterization of murine mitochondria-associated neutral sphingomyelinase (MA-nSMase), the mammalian sphingomyelin phosphodiesterase 5Neutral sphingomyelinase 2 (smpd3) in the control of postnatal growth and developmentNeutral Sphingomyelinase-2 Deficiency Ameliorates Alzheimer's Disease Pathology and Improves Cognition in the 5XFAD MouseIdentification of Mg2+ -dependent neutral sphingomyelinase 1 as a mediator of heat stress-induced ceramide generation and apoptosis.Stress-induced sphingolipid signaling: role of type-2 neutral sphingomyelinase in murine cell apoptosis and proliferation.Sphingomyelinases: enzymology and membrane activity.Biochemical properties of mammalian neutral sphingomyelinase 2 and its role in sphingolipid metabolism.Neutral sphingomyelinase 1 deficiency in the mouse causes no lipid storage diseaseCaveolin-induced activation of the phosphatidylinositol 3-kinase/Akt pathway increases arsenite cytotoxicity.Stress-induced ceramide generation and apoptosis via the phosphorylation and activation of nSMase1 by JNK signaling.The neutral sphingomyelinase pathway regulates packaging of the prion protein into exosomes.Neutral sphingomyelinase activation precedes NADPH oxidase-dependent damage in neurons exposed to the proinflammatory cytokine tumor necrosis factor-αNitric oxide signalling with a special focus on lipid-derived mediators.Reproductive pathology and sperm physiology in acid sphingomyelinase-deficient miceSperm abnormalities in heterozygous acid sphingomyelinase knockout mice reveal a novel approach for the prevention of genetic diseases.Neutral sphingomyelinase (SMPD3) deficiency causes a novel form of chondrodysplasia and dwarfism that is rescued by Col2A1-driven smpd3 transgene expressionNeutral sphingomyelinase (SMPD3) deficiency disrupts the Golgi secretory pathway and causes growth inhibition.Mammalian neutral sphingomyelinases: regulation and roles in cell signaling responses.The neutral sphingomyelinase family: identifying biochemical connections.Ceramide and mitochondria in ischemic brain injury.The roles of neutral sphingomyelinases in neurological pathologies.Ceramide function in the brain: when a slight tilt is enough.Sphingolipid metabolism and neutral sphingomyelinases.Sphingolipid metabolism and interorganellar transport: localization of sphingolipid enzymes and lipid transfer proteins.Identification and characterization of Laodelphax striatellus (Insecta: Hemiptera: Delphacidae) neutral sphingomyelinase.Biochemical identification of a neutral sphingomyelinase 1 (NSM1)-like enzyme as the major NSM activity in the DT40 B-cell line: absence of a role in the apoptotic response to endoplasmic reticulum stress.Enzymatic measurement of phosphatidylserine in cultured cells.Critical determinants of mitochondria-associated neutral sphingomyelinase (MA-nSMase) for mitochondrial localization.Unsaturated fatty acid-mediated decreases in sterol regulatory element-mediated gene transcription are linked to cellular sphingolipid metabolism.Irreversible inactivation of magnesium-dependent neutral sphingomyelinase 1 (NSM1) by peroxynitrite, a nitric oxide-derived oxidant.Exercise and training effects on ceramide metabolism in human skeletal muscle.Identification and evaluation of neutral sphingomyelinase 2 inhibitors.SMPD3 deficiency perturbs neuronal proteostasis and causes progressive cognitive impairment.Ordering of ceramide formation, caspase activation, and Bax/Bcl-2 expression during etoposide-induced apoptosis in C6 glioma cells.
P2860
Q22254143-3DB919F5-365E-4EEF-B590-EE38BA77447FQ26822419-004563FF-A5ED-4409-B4AA-54FE593FBED4Q27022944-3C147283-6627-4822-BDAE-DB5C15943323Q28265196-51AC3250-E035-474B-A8E7-2B7221211C31Q28346433-AB1091F1-F639-463B-BBC8-5927066FA4A3Q28363285-301F9535-E96B-4820-954F-43B1E7263147Q28590499-4982BF35-1143-46A9-8BDA-485CBC251216Q28595054-CFF54BCC-6394-4025-81F7-FD8629CB340EQ30363059-C926B501-1792-4ADF-9500-26394F9BBE52Q33357486-502DD5D4-1E8B-4E70-9B63-7C6DF1B7E110Q33547469-3A4A31A7-1F68-4784-9F15-E1EE7228E592Q34156320-741015D6-1A80-41D5-8B7F-E4A9537094EDQ34174979-98F34FAA-54A7-48B6-82AA-4231F4E6B6A6Q34280470-48E19891-D225-46A0-84F7-70057DFB2517Q34784483-FD082751-A586-490A-A601-B686B0F44C55Q34924126-9F3B38F2-BEAF-4231-8A6D-077561EEC116Q35055528-97D9F7BB-ED3E-4C15-83D8-423E871A3DFEQ35555862-AA897B34-0EC8-41BA-957A-C5973B8735DAQ35605781-721414E1-3CEF-4711-A02A-6B41DAA60A56Q35789032-ABBC3A66-14A6-4FE5-857D-5E5AF0CBA0D8Q35855567-073F8E86-B67B-4580-B162-45260548DAAEQ35928277-275099A7-D46F-4288-B0D6-F44B20532227Q37603258-C030F964-50A5-49FF-AADF-9C3091CDCEAEQ37765497-2C2813E7-E77B-4D4B-ACF5-09128B7F1BDBQ37805088-DCD1675D-AEAF-434A-96D7-05CD4D6D4E9CQ37970353-536BCB6F-500C-4F82-8517-5B17340DEF7FQ37975165-DF736A20-8489-44CA-83B2-3C1B908C1681Q38021345-BC921480-88AA-47DA-8126-A6F4F56549BDQ38098404-3CD4CEF7-0DA6-4BB8-A269-7EDB6E46AC7DQ38266425-7781178B-4D87-4C79-8CBD-32C0AA5CEAA8Q38856868-3250302D-3FC2-4075-B5CD-97E40E858C4EQ40724103-F0ECB899-2412-4147-AD3D-DDB5803A3710Q40756291-0AB1AA89-4761-4AF7-B6B4-3F0C24FFA9A9Q40796143-2FE6994B-9353-4378-8C4E-E72ED662BF0EQ43798531-9963670D-C0AB-4140-B67E-8157ADC5BAA0Q44205610-06E9747C-3E7A-459B-96F7-A3197DF1408AQ44861257-EA006201-4AF6-4583-8618-31F6D64B2E10Q53435154-FD09F6AF-3F9B-4861-BFF5-56DD1DF7EC4EQ55318089-5381B3EA-A97C-47F8-9E82-067CF4E5024BQ55475037-A03436FC-A10D-406E-AA38-7A512D8AF1F3
P2860
Characterization and subcellular localization of murine and human magnesium-dependent neutral sphingomyelinase
description
2000 nî lūn-bûn
@nan
2000 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Characterization and subcellul ...... ndent neutral sphingomyelinase
@ast
Characterization and subcellul ...... ndent neutral sphingomyelinase
@en
Characterization and subcellul ...... ndent neutral sphingomyelinase
@nl
type
label
Characterization and subcellul ...... ndent neutral sphingomyelinase
@ast
Characterization and subcellul ...... ndent neutral sphingomyelinase
@en
Characterization and subcellul ...... ndent neutral sphingomyelinase
@nl
prefLabel
Characterization and subcellul ...... ndent neutral sphingomyelinase
@ast
Characterization and subcellul ...... ndent neutral sphingomyelinase
@en
Characterization and subcellul ...... ndent neutral sphingomyelinase
@nl
P2093
P2860
P356
P1476
Characterization and subcellul ...... ndent neutral sphingomyelinase
@en
P2093
P2860
P304
P356
10.1074/JBC.275.8.5710
P407
P577
2000-02-25T00:00:00Z